Abstract
Group A streptococcus (GAS) or Streptococcus pyogenes has been recognised as an important human pathogen since early days of modern microbiology, and it remains among the top ten causes of mortality from an infectious disease. Clinical manifestations attributable to this organism are perhaps the most diverse of any single human pathogen. These encompass invasive GAS infections, with high mortality rates despite effective antimicrobials, toxin-mediated diseases including scarlet fever and streptococcal toxic shock syndrome, the autoimmune sequelae of rheumatic fever and glomerulonephritis with potential for long-term disability, and nuisance manifestations of superficial skin and pharyngeal infection, which continue to consume a sizable proportion of healthcare resources. Although an historical perspective indicates major overall reductions in GAS infection rates in the modern era, chiefly as a result of widespread improvements in socioeconomic circumstances, this pathogen remains as a leading infectious cause of global morbidity and mortality. More than 18 million people globally are estimated to suffer from serious GAS disease. This burden disproportionally affects least affluent populations, and is a major cause of illness and death among children and young adults, including pregnant women, in low-resource settings. We review GAS transmission characteristics and prevention strategies, historical and geographical trends and report on the estimated global burden disease attributable to GAS. The lack of systematic reporting makes accurate estimation of rates difficult. This highlights the need to support improved surveillance and epidemiological research in low-resource settings, in order to enable better assessment of national and global disease burdens, target control strategies appropriately and assess the success of control interventions.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Adriaanse AH, Pel M, Bleker OP (2000) Semmelweis: the combat against puerperal fever. Eur J Obstet Gynecol Reprod Biol 90:153–158
Andrews RM, McCarthy J, Carapetis JR, Currie BJ (2009) Skin disorders, including pyoderma, scabies, and tinea infections. Pediatr Clin North Am 56:1421–1440
Baddour LM, Bisno AL (1982) Recurrent cellulitis after saphenous venectomy for coronary bypass surgery. Ann Intern Med 97:493–496
Berkley JA, Lowe BS, Mwangi I, Williams T, Bauni E, Mwarumba S et al (2005) Bacteremia among children admitted to a rural hospital in Kenya. N Engl J Med 352:39–47
Bisno AL, Stevens DL (1996) Streptococcal infections of skin and soft tissues. N Engl J Med 334:240–245
Bisno AL, Stevens DL (2000) Streptococcus pyogenes (including Streptococcal toxic shock syndrome and necrotising fasciitis). In: Mandell GL, Bennett JE, Dolin R (eds) Mandell, Douglas and Bennett’s principles and practice of infectious diseases, 5th edn. Churchill Livingstone, Philadelphia, pp 2101–2117
Bloom BR, Murray CJ (1992) Tuberculosis: commentary on a reemergent killer. Science 257:1055–1064
Brennan RE, Patel MS (1990) Acute rheumatic fever and rheumatic heart disease in a rural central Australian aboriginal community. Med J Aust 153:335, 338–339
Brown A, Purton L, Schaeffer G, Wheaton G (2003) Central Australian Rheumatic Heart Disease Control Program. Central Australian RHD Steering Committee. Northern Territory Disease Control Bulletin 10:1–8
Bryant PA, Robins-Browne R, Carapetis JR, Curtis N (2009) Some of the people, some of the time: susceptibility to acute rheumatic fever. Circulation 119:742–753
Carapetis JR (1998) Ending the heartache: the epidemiology and control of acute rheumatic fever and rheumatic heart disease in the top end of the Northern Territory, University of Sydney
Carapetis JR (2008) Rheumatic heart disease in Asia. Circulation 118:2748–2753
Carapetis JR (2009) Epidemiology of group A streptococcus in Australia. Microbiol Australia 30:171–176
Carapetis JR, Currie BJ (1999) Mortality due to acute rheumatic fever and rheumatic heart disease in the Northern territory: a preventable cause of death in aboriginal people. Aust N Z J Public Health 23:159–163
Carapetis JR, Walker AM, Hibble M, Sriprakash KS, Currie BJ (1999) Clinical and epidemiological features of group A streptococcal bacteraemia in a region with hyperendemic superficial streptococcal infection. Epidemiol Infect 122:59–65
Carapetis JR, Currie BJ, Mathews JD (2000) Cumulative incidence of rheumatic fever in an endemic region: a guide to the susceptibility of the population? Epidemiol Infect 124:239–244
Carapetis JR, Steer AC, Mulholland EK, Weber M (2005a) The global burden of group A streptococcal diseases. Lancet Infect Dis 5:685–694
Carapetis JR, McDonald M, Wilson NJ (2005b) Acute rheumatic fever. Lancet 366:155–168
Centers for Disease Control, Prevention (1999) Nosocomial group A streptococcal infections associated with asymptomatic health-care workers–Maryland and California, 1997. MMWR Morb Mortal Wkly Rep. 48:163-166
Centers for Disease Control and Prevention (CDC) (2001) Soft tissue infections among injection drug users—San Francisco, California, 1996–2000. MMWR Morb Mortal Wkly Rep 50(19):381–384. http://www.ncbi.nlm.nih.gov/pubmed/11465906
Centers for Disease Control, Prevention (2002) Outbreak of group A streptococcal pneumonia among Marine Corps recruits, 1 Nov–20 Dec, California. MMWR Morb Mortal Wkly Rep. 2003, 52:106–109
Cernay J, Rusnak M, Raisova A (1993) Incidence of rheumatic fever in Slovakia during the last 20 years. Ceskoslovenska Pediatrie 48:79–83
Coburn AF, Young DC (1949) The epidemiology of hemolytic streptotoccus during World War II in the United States Navy. Williams and Wilkins, Baltimore
Cone LA, Woodard DR, Schlievert PM, Tomory GS (1987) Clinical and bacteriologic observations of a toxic shock-like syndrome due to Streptococcus pyogenes. N Engl J Med 317:146–149
Danchin MH, Rogers S, Selvaraj G, Kelpie L, Rankin P, Vorich R et al (2004) The burden of group A streptococcal pharyngitis in Melbourne families. Indian J Med Res 119(Suppl):144–147
Davies HD, McGeer A, Schwartz B, Green K, Cann D, Simor AE et al (1996) Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal study group. N Engl J Med 335:547–554
Del Mar CB, Glasziou PP, Spinks AB (2006) Antibiotics for sore throat. Cochrane database of systematic reviews. :CD000023
Ewald DP, Hall GV, Franks CC (2003) An evaluation of a SAFE-style trachoma control program in Central Australia. Med J Aust 178:65–68
Ferrieri P (2002) Proceedings of the Jones Criteria workshop. Circulation 106:2521–2523
Gemmell CG, Peterson PK, Schmeling D, Kim Y, Mathews J, Wannamaker L et al (1981) Potentiation of opsonization and phagocytosis of Streptococcus pyogenes following growth in the presence of clindamycin. J Clin Invest 67:1249–1256
Hanna JN, Clark MF (2010) Acute rheumatic fever in Indigenous people in North Queensland: some good news at last? Med J Aust 192:581–584
Harper A for the Centre for Maternal and Child Enquiries (2011) Sepsis (Chapter 7). In: Saving mothers’ lives. Reviewing maternal deaths to make motherhood safer, 2006–2008. BJOG 118 (Supp 1):85–96
Health Protection Agency Group A Streptococcus Working Group (2004) Interim UK guidelines for management of close community contacts of invasive group A streptococcal disease. Commun Dis Public Health 7:354–361
Heggie AD, Jacobs MR, Linz PE, Han DP, Kaplan EL, Boxerbaum B (1992) Prevalence and characteristics of pharyngeal group A beta-hemolytic streptococci in US Navy recruits receiving benzathine penicillin prophylaxis. J Infect Dis 166:1006–1013
Hoge CW, Schwartz B, Talkington DF, Breiman RF, MacNeill EM, Englender SJ (1993) The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock-like syndrome: a retrospective population-based study. JAMA 269:384–389
Hook EW 3rd, Hooton TM, Horton CA, Coyle MB, Ramsey PG, Turck M (1986) Microbiologic evaluation of cutaneous cellulitis in adults. Arch Intern Med 146:295–297
Horn DL, Zabriskie JB, Austrian R, Cleary PP, Ferretti JJ, Fischetti VA et al (1998) Why have group A streptococci remained susceptible to penicillin? Report on a symposium. Clin Infect Dis 26:1341–1345
Hoy WE, Mathews JD, McCredie DA, Pugsley DJ, Hayhurst BG, Rees M et al (1998) The multidimensional nature of renal disease: rates and associations of albuminuria in an Australian Aboriginal community. Kidney Int 54:1296–1304
Jaine R, Baker M, Venugopal K (2008) Epidemiology of acute rheumatic fever in New Zealand 1996–2005. J Paediatr Child Health 44:564–571
Kaplan EL (1993) T. Duckett Jones Memorial Lecture. Global assessment of rheumatic fever and rheumatic heart disease at the close of the century. Influences and dynamics of populations and pathogens: a failure to realize prevention? Circulation 88:1964–1972
Kaplan EL (2009) Some things never change! Clin Infect Dis 48:1220–1222
Kaplan EL, Top FH Jr, Dudding BA, Wannamaker LW (1971) Diagnosis of streptococcal pharyngitis: differentiation of active infection from the carrier state in the symptomatic child. J Infect Dis 123:490–501
Katz AR, Morens DM (1992) Severe streptococcal infections in historical perspective. Clin Infect Dis 14:298–307
Kim S, Lee NY (2004) Epidemiology and antibiotic resistance of group A streptococci isolated from healthy schoolchildren in Korea. J Antimicrob Chemother 54:447–450
Kohler W, Gerlach D, Knoll H (1987) Streptococcal outbreaks and erythrogenic toxin type A. Zentralbl Bakteriol Mikrobiol Hyg A 266:104–115
Kurahara DK, Grandinetti A, Galario J, Reddy DV, Tokuda A, Langan S et al (2006) Ethnic differences for developing rheumatic fever in a low-income group living in Hawaii. Ethn Dis 16:357–361
Lamagni TL, Efstratiou A, Vuopio-Varkila J, Jasir A, Schalen C, Strep E (2005) The epidemiology of severe Streptococcus pyogenes associated disease in Europe. Euro Surveill 10:179–184
Leach AJ, Shelby-James TM, Mayo M, Gratten M, Laming AC, Currie BJ et al (1997) A prospective study of the impact of community-based azithromycin treatment of trachoma on carriage and resistance of Streptococcus pneumoniae. Clin Infect Dis 24:356–362
Lehmann D, Tennant MT, Silva DT, McAullay D, Lannigan F, Coates H et al (2003) Benefits of swimming pools in two remote Aboriginal communities in Western Australia: intervention study. BMJ 327:415–419
Lennon D, Martin D, Wong E, Taylor LR (1988) Longitudinal study of post streptococcal disease in Auckland; rheumatic fever, glomerulonephritis, epidemiology and M typing 1981–86. N Z Med J 101:396–398
Lennon D, Stewart J, Farrell E, Palmer A, Mason H (2009) School-based prevention of acute rheumatic fever: a group randomized trial in New Zealand. Pediatr Infect Dis J 28:787–794
Lue HC, Chen CL, Wei H, Okuni M, Mabilangan LM, Dharmasakti D et al (1979) The natural history of rheumatic fever and rheumatic heart disease in the Orient. Jpn Heart J 20:237–252
Mahmood Z, Al Benna S, Nkere U, Murday A (2006) Decreased morbidity following long saphenous vein harvesting using a minimally invasive technique: a randomised controlled trial comparing two techniques for long saphenous vein harvest. J Cardiothorac Surg 1:15
Majeed HA, Al-Doussary L, Moussa MM, Yusuf AR, Suliman AH (1993) Office diagnosis and management of group A streptococcal pharyngitis employing the rapid antigen detecting test. A 1-year prospective study of reliability and cost in primary care centres. Ann Trop Paediatr 13:65–72
Manyemba J, Mayosi BM (2002) Penicillin for secondary prevention of rheumatic fever. Cochrane database of systematic reviews :CD002227
Marijon E, Ou P, Celermajer DS, Ferreira B, Mocumbi AO, Jani D et al (2007) Prevalence of rheumatic heart disease detected by echocardiographic screening. N Engl J Med 357:470–476
Marijon E, Mirabel M, Celermajer DS, Jouven X (2012) Rheumatic heart disease. Lancet 379:953–964
Marshall CS, Cheng AC, Markey PG, Towers RJ, Richardson LJ, Fagan PK et al (2011) Acute post-streptococcal glomerulonephritis in the Northern Territory of Australia: a review of 16 years data and comparison with the literature. Am J Trop Med Hyg 85:703–710
Martin PR, Hoiby EA (1990) Streptococcal serogroup A epidemic in Norway 1987–1988. Scand J Infect Dis 22:421–429
McDonald M, Currie BJ, Carapetis JR (2004) Acute rheumatic fever: a chink in the chain that links the heart to the throat? Lancet Infect Dis 4:240–245
McDonald MI, Towers RJ, Andrews RM, Benger N, Currie BJ, Carapetis JR (2006) Low rates of streptococcal pharyngitis and high rates of pyoderma in Australian aboriginal communities where acute rheumatic fever is hyperendemic. Clin Infect Dis 43:683–689
McNamara DR, Tleyjeh IM, Berbari EF, Lahr BD, Martinez JW, Mirzoyev SA et al (2007) Incidence of lower-extremity cellulitis: a population-based study in Olmsted county. Minnesota. Mayo Clin Proc 82:817–821
Milne LM, Lamagni T, Efstratiou A, Foley C, Gilman J, Lilley M et al (2011) Streptococcus pyogenes cluster in a care home in England April to June 2010. Euro Surveill 16:20021
Milne RJ, Lennon D, Stewart JM, Vander Hoorn S, Scuffham PA (2012a). Mortality and hospitalisation costs of rheumatic fever and rheumatic heart disease in New Zealand. J Paediatr Child Health 48:692–697
Milne RJ, Lennon DR, Stewart JM, Vander Hoorn S, Scuffham PA (2012b) Incidence of acute rheumatic fever in New Zealand children and youth. J Paediatr Child Health 48:685–691
Morita JY, Kahn E, Thompson T, Laclaire L, Beall B, Gherardi G et al (2000) Impact of azithromycin on oropharyngeal carriage of group A Streptococcus and nasopharyngeal carriage of macrolide-resistant Streptococcus pneumoniae. Pediatr Infect Dis J 19:41–46
Myo Thet H, Thein N, Nyan T, May Mon K (1992) Prevalence of cardiovascular diseases in rural area of Hmawbi and urban Yangon city. Asia Pac J Public Health 6:188–194
Nandi S, Kumar R, Ray P, Vohra H, Ganguly NK (2001) Group A streptococcal sore throat in a periurban population of northern India: a one-year prospective study. Bull World Health Organ 79:528–533
Nathan L, Peters MT, Ahmed AM, Leveno KJ (1993) The return of life-threatening puerperal sepsis caused by group A streptococci. Am J Obstet Gynecol 169:571–572
New South Wales Health (2012) Invasive group A Streptococcus—Control guidelines for NSW Public Health Units 2015. [cited October 2012].http://www.health.nsw.gov.au/factsheets/guideline/maternal_sepsis.html
Noonan S, Zurynski YA, Currie BJ, McDonald M, Wheaton G, Nissen M, et al. (2012) A National Prospective Surveillance Study of Acute Rheumatic Fever in Australian Children. Pediatr Infect Dis J [Epub ahead of print]
Norton R, Smith HV, Wood N, Siegbrecht E, Ross A, Ketheesan N (2004) Invasive group A streptococcal disease in North Queensland (1996–2001). Indian J Med Res 119(Suppl):148–151
Omar A (1995) Pattern of acute rheumatic fever in a local teaching hospital. Medical J Malaysia 50:125–130
Ontario Ministry of Health (2005) Guidelines for management of contacts of cases of invasive group A streptococcal disease (GAS) including streptococcal toxic shock syndrome (STSS) and necrotising fasciitis (NF) [cited October 2012]. http://microbiology.mtsinai.on.ca/protocols/pdf/k5c.pdf
Padmavati S, Sharma KB, Jayaram O (1973) Epidemiology and prophylaxis of rheumatic fever in Delhi–a five year follow-up. Singapore Med J 14:457–461
Parnaby MG, Carapetis JR (2010) Rheumatic fever in indigenous Australian children. J Paediatr Child Health 46:527–533
Pastore S, De Cunto A, Benettoni A, Berton E, Taddio A, Lepore L (2011) The resurgence of rheumatic fever in a developed country area: the role of echocardiography. Rheumatology 50:396–400
Prevention of Invasive Group ASIWP (2002) Prevention of invasive group A streptococcal disease among household contacts of case patients and among postpartum and postsurgical patients: recommendations from the Centers for Disease Control and Prevention. Clin Infect Dis 35:950–959
Purcell B, Samuelsson S, Hahne SJ, Ehrhard I, Heuberger S, Camaroni I et al (2004) Effectiveness of antibiotics in preventing meningococcal disease after a case: systematic review. BMJ 328:1339
Quinn RW (1989) Comprehensive review of morbidity and mortality trends for rheumatic fever, streptococcal disease, and scarlet fever: the decline of rheumatic fever. Rev Infect Dis 11:928–953
RHD Australia (ARF/RHD writing group) (2012) The Australian guideline for prevention, diagnosis and management of acute rheumatic fever and rheumatic heart disease (2nd edition). National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand [cited Oct 2012]. http://www.rhdaustralia.org.au/sites/default/files/guideline_0.pdf
Rheumatic fever working party (1960) The evolution of rheumatic heart disease in children. Five-year report of a co-operative clinical trial of A.C.T.H. cortisone, and aspirin. Circulation 22:503–515
Richmond P, Harris L (1998) Rheumatic fever in the Kimberley region of Western Australia. J Trop Pediatr 44:148–152
Rizvi SF, Khan MA, Kundi A, Marsh DR, Samad A, Pasha O (2004) Status of rheumatic heart disease in rural Pakistan. Heart 90:394–399
Sartain JB, Anderson NL, Barry JJ, Boyd PT, Howat PW (2012) Rheumatic heart disease in pregnancy—cardiac and obstetric outcomes. Intern Med J [epub ahead of print]
Sawhney H, Aggarwal N, Suri V, Vasishta K, Sharma Y, Grover A (2003) Maternal and perinatal outcome in rheumatic heart disease. Int J Gynaecol Obstet 80:9–14
Seckeler MD, Hoke TR (2011) The worldwide epidemiology of acute rheumatic fever and rheumatic heart disease. Clin Epidemiol 3:67–84
Seppala H, Klaukka T, Vuopio-Varkila J, Muotiala A, Helenius H, Lager K et al (1997) The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance. N Engl J Med 337:441–446
Shelby-James TM, Leach AJ, Carapetis JR, Currie BJ, Mathews JD (2002) Impact of single dose azithromycin on group A streptococci in the upper respiratory tract and skin of Aboriginal children. Pediatr Infect Dis J 21:375–380
Sjoblom AC, Eriksson B, Jorup-Ronstrom C, Karkkonen K, Lindqvist M (1993) Antibiotic prophylaxis in recurrent erysipelas. Infection 21:390–393
Smith A, Lamagni TL, Oliver I, Efstratiou A, George RC, Stuart JM (2005) Invasive group A streptococcal disease: Should close contacts routinely receive antibiotic prophylaxis? The Lancet Infect Dis 5:494–500
Smith MT, Lester-Smith D, Zurynski Y, Noonan S, Carapetis JR, Elliott EJ (2011) Persistence of acute rheumatic fever in a tertiary children’s hospital. J Paediatr Child Health 47:198–203
Steer AC, Adams J, Carlin J, Nolan T, Shann F (1999) Rheumatic heart disease in school children in Samoa. Arch Dis Child 81:372
Steer AC, Jenney AJ, Oppedisano F, Batzloff MR, Hartas J, Passmore J et al (2008) High burden of invasive beta-haemolytic streptococcal infections in Fiji. Epidemiol Infect 136:621–627
Steer AC, Batzloff MR, Mulholland K, Carapetis JR (2009a) Group A streptococcal vaccines: facts versus fantasy. Curr Opin Infect Dis 22:544–552
Steer AC, Law I, Matatolu L, Beall BW, Carapetis JR (2009b) Global emm type distribution of group A streptococci: systematic review and implications for vaccine development. Lancet Infect Dis 9:611–616
Stevens DL (1995) Streptococcal toxic-shock syndrome: spectrum of disease, pathogenesis, and new concepts in treatment. Emerg Infect Dis 1:69–78
Stevens DL, Maier KA, Mitten JE (1987) Effect of antibiotics on toxin production and viability of Clostridium perfringens. Antimicrob Agents Chemother 31:213–218
Stevens DL, Tanner MH, Winship J, Swarts R, Ries KM, Schlievert PM et al (1989) Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N Engl J Med 321:1–7
Stromberg A, Romanus V, Burman LG (1991) Outbreak of group A streptococcal bacteremia in Sweden: an epidemiologic and clinical study. J Infect Dis 164:595–598
Svensson N, Oberg S, Henriques B, Holm S, Kallenius G, Romanus V et al (2000) Invasive group A streptococcal infections in Sweden in 1994 and 1995: epidemiology and clinical spectrum. Scand J Infect Dis 32:609–614
Tanz RR, Shulman ST, Barthel MJ, Willert C, Yogev R (1985) Penicillin plus rifampin eradicates pharyngeal carriage of group A streptococci. J Pediatrics 106:876–880
The WHO Young Infants Study Group (1999) Bacterial etiology of serious infections in young infants in developing countries: Results of a multicenter study. Pediatr Infect Dis J 18:S17–S22
The Working Group on Severe Streptococcal Infections (1993) Defining the group A streptococcal toxic shock syndrome: Rationale and consensus definition. The Working Group on Severe Streptococcal Infections. JAMA 269:390–391
Tibazarwa KB, Volmink JA, Mayosi BM (2008) Incidence of acute rheumatic fever in the world: a systematic review of population-based studies. Heart 94:1534–1540
Veasy LG, Wiedmeier SE, Orsmond GS, Ruttenberg HD, Boucek MM, Roth SJ et al (1987) Resurgence of acute rheumatic fever in the intermountain area of the United States. N Engl J Med 316:421–427
Wannamaker LW (1954) The epidemiology of streptococcal infections. Columbia University Press, New York
Wasserzug O, Valinsky L, Klement E, Bar-Zeev Y, Davidovitch N, Orr N et al (2009) A cluster of ecthyma outbreaks caused by a single clone of invasive and highly infective Streptococcus pyogenes. Clin Infect Dis 48:1213–1219
White AV, Hoy WE, McCredie DA (2001) Childhood post-streptococcal glomerulonephritis as a risk factor for chronic renal disease in later life. Med J Aust 174:492–496
WHO Expert consultation on rheumatic fever and rheumatic heart disease (2001) Rheumatic fever and rheumatic heart disease: report of a WHO Expert Consultation, Geneva, 29 Oct–1 Nov. WHO Technical Report Series 923. 2004 [cited October 2012]. http://whqlibdoc.who.int/trs/WHO_TRS_923.pdf
Williams AW, Gurley CR, Sobel E, Castelda M (1932) Milk-borne Septic Sore Throat and Scarlet Fever and Their Relation to Beta Hemolytic Streptococci. J Bacteriol 23:241–258
World Health Organisation (1990) Global Burden of Disease [cited Oct 2012]. http://www.who.int/topics/global_burden_of_disease/en/
World Health Organisation (2011) Global Tuberculosis Control: WHO Report. WHO Library Cataloguing-in-Publication Data. 2011 [cited Oct 2012]. http://www.who.int/tb/publications/global_report/2011/gtbr11_full.pdf
World Health Organization (2005) The Current Evidence for the Burden of Group A Streptococcal Diseases. Discussion papers on Child Health. Department of Child and Adolescent Health and Development, WHO. [cited Oct 2012]. http://whqlibdoc.who.int/hq/2005/WHO_FCH_CAH_05.07.pdf
Yagupsky P, Landau D, Beck A, Dagan R (1995) Carriage of Streptococcus pyogenes among infants and toddlers attending day-care facilities in closed communities in southern Israel. Eur J Clin Microbiol Infect Dis 14:54–58
Acknowledgment
APR is supported by National Health and Medical Research Council (Australia) Fellowship 1016567.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Ralph, A.P., Carapetis, J.R. (2012). Group A Streptococcal Diseases and Their Global Burden. In: Chhatwal, G. (eds) Host-Pathogen Interactions in Streptococcal Diseases. Current Topics in Microbiology and Immunology, vol 368. Springer, Berlin, Heidelberg. https://doi.org/10.1007/82_2012_280
Download citation
DOI: https://doi.org/10.1007/82_2012_280
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-36339-9
Online ISBN: 978-3-642-36340-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)